INTENSITY THERAPEUTICS, INC. (INTS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | BENDER LEWIS H | director | A | 37,749 | 6.11 | $230,646 |
| 2025-12-31 | Wesolowski John M | officer | A | 8,918 | 0.26 | $2,319 |
| 2025-12-31 | Talamo Joseph | officer | A | 14,482 | 0.26 | $3,765 |
| 2025-06-30 | Wesolowski John M | officer | A | 69,745 | 0.26 | $18,134 |
| 2025-06-30 | Talamo Joseph | officer | A | 14,179 | 0.26 | $3,687 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.